Riskpilot← Back to searchSign inGet full accessAlcmaeon AB
ABActiveOrg 5567381834Semestervägen 9 BGeneral medical practice activities · NACE 8621Est. 20072 employees
Revenue 2025
SEK 2,3M
+14% vs 2024
EBITDA margin
-6.1%
-80% vs 2024
Equity ratio
17.5%
Financial strength
Net profit 2025
SEK -74K
2 employees
| Revenue | SEK 2,3M | +14% |
| EBITDA | SEK -141K | -80% |
| Net profit | SEK -74K | — |
| Total assets | SEK 724K | +8% |
| Equity | SEK 126K | +26% |
| Employees | 2 | — |
Legal name
Alcmaeon AB
Org number
5567381834
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 september 2007
Share capital
SEK 200 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Titova, Irina
Company purpose
Föremålet för bolagets verksamhet ska vara att bedriva sjukvård med konsultation och information samt ledarskapsutveckling och pedagogisk utveckling samt därmed förenlig verksamhet.
Address
Semestervägen 9 B
Phone
+46704711972
Email
irinatitova027@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 746 | 1 867 | 1 936 | 2 037 | 2 319 |
| Staff expenses | — | — | −921 | — | −911 |
| EBITDA | 152 | 512 | 323 | −78 | −141 |
| Depreciation & amort. | −0 | −0 | — | −0 | −0 |
| EBIT | 152 | 512 | 323 | −78 | −141 |
| Net financials | −6 | −1 | 0 | −1 | −0 |
| Profit before tax | 149 | 511 | 242 | 1 | −74 |
| Tax | −35 | −105 | −51 | −1 | −0 |
| Net profit | 114 | 406 | 191 | 0 | −74 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 903 | 1 256 | 1 099 | 668 | 724 |
| Equity | 384 | 629 | 370 | 100 | 126 |
| Long-term debt | 0 | 0 | — | 0 | 100 |
| Short-term debt | 452 | 561 | 583 | 502 | 497 |
| Total debt | 452 | 561 | 583 | 502 | 597 |
EBITDA margin
-6.1%
This company
15.8%
Market median
-139% vs market
20212025
Equity ratio
17.5%
This company
38.2%
Market median
-54% vs market
20212025
Return on equity
-58.2%
This company
18.4%
Market median
-416% vs market
20212025
Net profit margin
-3.2%
This company
8.1%
Market median
-140% vs market
20212025
Asset turnover
3.20×
This company
1.12×
Market median
+186% vs market
20212025
Debt / equity
4.73×
This company
0.62×
Market median
-663% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alcmaeon AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anastassia Titova | Deputy Board Member | 0 companies |
| Andrej Vladimirovitj Titov | Board of Directors | 0 companies |
| Irina Titova | Chairman | 0 companies |